Lipid-lowering drugs: Beyond lowering lipid levels to their influence on cardiac arrhythmias
- 31 August 2006
- journal article
- editorial
- Published by Elsevier in Heart Rhythm
- Vol. 3 (8) , 887-888
- https://doi.org/10.1016/j.hrthm.2006.05.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunctionPublished by Elsevier ,2006
- Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-IIJournal of the American College of Cardiology, 2006
- Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillatorsEuropean Heart Journal, 2006
- Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid IntakeCirculation, 2005
- The pleiotropic effects of statinsCurrent Opinion in Cardiology, 2005
- Inflammation as a Risk Factor for Atrial FibrillationCirculation, 2003
- Are lipid-lowering drugs also antiarrhythmic drugs?Journal of the American College of Cardiology, 2003
- C-Reactive Protein Elevation in Patients With Atrial ArrhythmiasCirculation, 2001
- Histological Substrate of Atrial Biopsies in Patients With Lone Atrial FibrillationCirculation, 1997
- The best antiarrhythmic agent will be a lipid-lowering agentThe American Journal of Cardiology, 1990